Statins underused in diabeticsU.S. researcher calls for more integrated approach to treating hyperglycemia and dyslipidemia to lower cardiovascular risks Dialing up diabetes data Sensor-augmented insulin pump pays off in type 1 diabetes Technology helps patients of all ages reach HbA1c targets by monitoring blood-glucose trends Guide to OTC Health Management: Diabetes and lifestyle Using food and fitness to manage diabetes FDA committees split on rosiglitazone Market withdrawal is most popular option, but not a majority vote Team care model for diabetes gaining support Division of tasks among care providers makes use of specialized training to improve patients’ understanding Rosiglitazone controversy continues to smolder Ask the Experts: DPP-4 inhibitors in the management of type 2 diabetes Q. What is the recommended role of DPP-4 inhibitors, such as sitagliptin and saxagliptin, in the management of type 2 diabetes? Low-dose combo therapy fends off diabetes Canadian trial of rosiglitazone-metformin pill not powered for adverse cardiovascular events Canadian researchers disagree on halting rosiglitazone trial Canadian researchers disagree on halting trial of diabetes drug rosiglitazone First Previous 51 52 53 54 55 Next Last
